Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,132 | 42,229 | 29,378 | 31,465 | 25,830 |
| Marketable Securities | 829 | 753 | N/A | N/A | N/A |
| Receivables | 2,068 | 1,645 | 2,469 | 3,750 | 1,143 |
| Inventories | N/A | N/A | 260 | 297 | 299 |
| Other current assets | 0 | 0 | 506 | 0 | 0 |
| TOTAL | $32,907 | $47,237 | $34,365 | $37,004 | $28,544 |
| Non-Current Assets | |||||
| PPE Net | 8,932 | 7,539 | 6,781 | 5,652 | 2,865 |
| Investments And Advances | 4,436 | 4,671 | 0 | 0 | 0 |
| Intangibles | 32,278 | 33,592 | 34,906 | 36,220 | 37,534 |
| Other Non-Current Assets | 1,561 | 1,621 | 807 | 734 | 760 |
| TOTAL | $47,207 | $47,423 | $42,494 | $42,606 | $41,159 |
| Total Assets | $80,114 | $94,660 | $76,859 | $79,610 | $69,704 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,674 | 9,377 | 7,793 | 6,604 | 6,322 |
| TOTAL | $13,669 | $12,462 | $10,336 | $9,192 | $8,203 |
| Non-Current Liabilities | |||||
| Long Term Debt | 220 | 220 | 268 | N/A | N/A |
| Deferred Revenues | 2,878 | 2,952 | 2,147 | 2,292 | 1,653 |
| Other Non-Current Liabilities | 12,687 | 8,032 | 7,222 | 5,666 | 3,022 |
| TOTAL | $6,853 | $5,751 | $5,589 | $5,467 | $3,989 |
| Total Liabilities | $20,522 | $18,213 | $15,925 | $14,659 | $12,192 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 94,962 | 94,894 | 94,894 | 83,281 | 83,266 |
| Common Shares | 275,238 | 273,979 | 248,069 | 235,555 | 234,752 |
| Retained earnings | -246,293 | -229,893 | -215,757 | -202,055 | -192,358 |
| Other shareholders' equity | 48,647 | 50,361 | 47,622 | 47,951 | 31,611 |
| TOTAL | $59,592 | $76,447 | $60,934 | $64,951 | $57,512 |
| Total Liabilities And Equity | $80,114 | $94,660 | $76,859 | $79,610 | $69,704 |